Dual inhibition of BCL2 and MCL1 using tumor targeted nanoparticles in lymphoma

Skip Ad in 6 Seconds

Browse Other Featured Videos

AML: the benefit of haploidentical donors

April 1st, 2020    18 Views

Mark Levis | ASCO 2018 | Maintenance therapy with gilteritinib in FLT3-ITD+ AML

June 5th, 2018    407 Views

Gene Mutation and Gene Fusion Research

iFCG proves promising for IGHV-mutated CLL

January 24th, 2020    60 Views

PTEN and Cancer

October 31st, 2017    1922 Views

Research in Diagnostic and Treatment Techniques

Exciting results for BCMA/CD3 bispecific PF-3135 in R/R MM

January 24th, 2020    77 Views

Dr. Woyach on the Utility of Time-Limited Therapies in CLL

April 9th, 2020    22 Views

Featured Videos from Sponsors

FFPE Slide Optimization Tips & Tricks

February 28th, 2020    289 Views

Bone Marrow & Blood Protocol Optimization Tips

March 19th, 2020    326 Views

Gene Inhibitors in Cancer

Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers

July 3rd, 2019    25 Views

Dr. Cortes Discusses FLT3 Inhibitors in AML

June 22nd, 2017    147 Views

Inspiring Discussions on Cytogenetics

Is the Study of Monogenic Diseases of the Immune System Relevant?

March 8th, 2020    575 Views

IPPCR: Developing Protocols and Manuals of Operating Procedures

March 12th, 2020    4204 Views

New Disease Research

Why should we target RUNX1 in AML treatment?

October 25th, 2019    76 Views

Cancer detecting and locating: cell-free DNA

September 28th, 2019    190 Views